Top Markets
Coin of the day
ProUroCare Medical Inc. ProUroCare Medical Inc.

ProUroCare Medical Inc.

PUMD
Rankning i aktier #42361
ProUroCare Medical Inc. is dedicated to developing advanced products for the... ProUroCare Medical Inc. is dedicated to developing advanced products for the accurate identification and detailed assessment of male prostate diseases. The company's primary offering is the ProUroScan System, an innovative prostate imaging solution. This system empowers physicians to precisely document prostate irregularities that have been initially discovered through a digital rectal examination. ProUroCare has entered into strategic agreements with Artann Laboratories Inc., covering the licensing, ongoing development, and market commercialization of its ProUroScan System. The company was established in 1999 and is headquartered in Eden Prairie, Minnesota.
Aktiekurs
$0.0001
Senast synkroniserad: 2026-08-11
Marknadsvärde
$1.86K
Förändring (1 dag)
0.00%
Förändring (1 år)
-50.00%
Land
US
Handel ProUroCare Medical Inc. (PUMD)

Kategori

Utdelningsavkastning för ProUroCare Medical Inc. (PUMD)
Utdelningsavkastningen (TTM) för ProUroCare Medical Inc. (aktiesymbol: PUMD) per 2026 är: 0
Genomsnittlig utdelningsavkastning de senaste 5 åren: 0.00%
Historik för utdelningsavkastning för ProUroCare Medical Inc. (PUMD) från 2026 till 2026
Utdelningsavkastning i slutet av varje år (TTM)
År Utdelningsavkastning Ändra
Inte tillräckligt med data för de angivna datumen.
Utdelningsavkastning (TTM) för liknande företag eller konkurrenter